Pursuant to Regulation 29 and 47 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, Pharmaids Pharmaceuticals has informed that the Board of Directors of the Company is scheduled to be held Monday, May 24, 2021 to consider the following business: Approval of audited financial results for the quarter and year ended 31.03.2021 and any Other matter with the permission of the Chair. Further, in accordance with its letter dated 31st March, 2021 the Trading window shall remain closed till 48 hours after communication of aforesaid Financial Results to the Stock Exchange.
The above information is a part of company’s filings submitted to BSE.
